Clinical Trials Browser

Phase 2 × Neoplasms × ixazomib × Clear all

NCT03590652 2025-10-21

Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma, Neoplasms